Evidence map›Paper›PMID 35704759›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Circadian protection against bacterial skin infection by epidermal CXCL14-mediated innate immunity.

Kojiro Tsujihana, Kosuke Tanegashima, Yasuko Santo, Hiroyuki Yamada, Sota Akazawa, Ryuta Nakao, Keiko Tominaga, Risa Saito, Yasumasa Nishito, Ryu-Ichiro Hata and 11 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The Influence of Circadian Rhythms on DNA Damage Repair in Skin Photoaging.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Modelling host-F1000Research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Kojiro TsujihanaGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.ORCID 0000-0002-8701-3706
Kosuke TanegashimaStem Cell Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.ORCID 0000-0001-8733-8538
Yasuko SantoGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
Hiroyuki YamadaGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
Sota AkazawaGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.ORCID 0000-0001-9655-9690
Ryuta NakaoDepartment of Pathology and Cell Regulation, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Keiko TominagaGraduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan.
Risa SaitoStem Cell Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
Yasumasa NishitoCore Technology and Research Center, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
Ryu-Ichiro HataOral Health Science Research Center, Graduate School of Kanagawa Dental University, Kanagawa 238-8580, Japan.ORCID 0000-0003-1455-8585
Tomonori NakamuraInstitute for the Advanced Study of Human Biology, Kyoto University Institute for Advanced Study, Kyoto University, Kyoto 606-8501, Japan.ORCID 0000-0002-0173-0780
Iori MuraiGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
Yuka KonoGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
Maho SugawaGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
Miki TaniokaDepartment of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Gyohei EgawaDepartment of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.ORCID 0000-0002-6101-4719
Masao DoiGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.ORCID 0000-0001-6264-9217
Tadashi IsaDepartment of Neuroscience, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.ORCID 0000-0001-5652-4688
Kenji KabashimaDepartment of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Takahiko HaraStem Cell Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.ORCID 0000-0002-6565-0720
Hitoshi OkamuraGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.ORCID 0000-0002-3013-4881
Kyoto University · JPTokyo Medical and Dental University · JPTokyo Metropolitan Institute of Medical Science · JPKanagawa Dental University · JPKyoto Prefectural University of Medicine · JPUbe Frontier University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidermis is the outermost layer of the skin and the body's primary barrier to external pathogens; however, the early epidermal immune response remains to be mechanistically understood. We show that the chemokine CXCL14, produced by epidermal keratinocytes, exhibits robust circadian fluctuations and initiates innate immunity. Clearance of the skin pathogen

Indexed as

EpidermisImmunity, InnateSkin Diseases, BacterialAnimalsChemokines, CXCCircadian ClocksKeratinocytesMammalsMiceStaphylococcal InfectionsStaphylococcus aureusChemokines, CXCCXCL14 protein, mousecircadian rhythmsCXCL14epidermisinnate immunityStaphylococcus aureus

Identifiers

PMID35704759
PMCPMC9231475
OpenAlexW4282933273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.